Avenue Therapeutics Inc (ATXI)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Alexandra MacLean |
| Employees: | 4 |
| Web site: | avenuetx.com |
|
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
781-652-4500
| |
| Date | Ratio |
|---|---|
| 2022-09-23 | 1:15 |
| 2024-04-26 | 1:75 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain.
Please log in first to see chart